Not too long ago, pharmaceutical giant Astrazeneca reached a £200bn valuation—one of only a few London-listed FTSE 100 ...

SALES: The London-listed group's third-quarter sales are forecast at $13.1 billion, according to the company-compiled consensus. This compares with $11.49 billion for the same period the year before.

The company has a 50 day simple moving average of £118.91 and a 200-day simple moving average of £121.58. AstraZeneca has a 1 ...

AstraZeneca said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not ...

The company believes Chinese authorities are probing allegations that two current and two former employees had illegally ...

While it remains unclear why AstraZeneca China President Leon Wang has been detained, news of his arrest comes just days ...

China's investigation of AstraZeneca's top executive in the country is raising questions about the company's tactics there.

Fiera Capital Corp trimmed its holdings in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 5.9% during the third quarter, according to the company in its most recent filing with the Securities and ...

Leerink Partners analyst Andrew Berens has maintained their bullish stance on AZN stock, giving a Buy rating on November 6. Andrew ...

AstraZeneca's price plunge following a fraud investigation in China could be just the time to buy AZN stock as big picture ...

AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here’s how Americans ...

Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese ...